Jobs / United States / Novartis Pharmaceuticals Corporation
TA Access Strategy Manager
Novartis Pharmaceuticals Corporation · 🇺🇸 Casablanca
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles5 certified filings for “Finance Manager” (Financial Quantitative Analysts) in NJ: $73k–$113k, median $113k. Most were filed at wage level II (60%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary The role is responsible for driving commercial growth by identifying and prioritizing Value & Access (V&A) opportunities across priority brands and the portfolio. It leads the development and deployment of access, pricing, and reimbursement strategies informed by deep healthcare system and customer insights. The role embeds system, policy, and payer insights into brand and portfolio strategies to support sustainable access outcomes. It works across functions to ensure V&A strategies are fully integrated into brand plans and local account implementation. The role ensures high‑quality, timely delivery of V&A solutions that maximize payer engagement and impact across the product lifecycle. Job Description Major Accountabilities Access Strategy, Positioning, and Portfolio Impact • Define national access, pricing, and reimbursement strategies per product and portfolio • Identify, evaluate, and prioritize V&A strategic choices that drive commercial growth • Translate global access guidance into locally relevant strategies • Ensure V&A strategies are embedded within integrated brand and portfolio plans • Align access strategies with product lifecycle stages, including launch and line extensions • Adapt strategies based on healthcare system, policy, and payer dynamics Insights and Customer Understanding • Deliver healthcare system and payer insights relevant to the portfolio to inform decisions • Generate in‑depth customer and system insights to shape V&A and Therapeutic Area (TA) strategies • Embed customer, policy, and system insights consistently across the organization • Translate insights into actionable V&A strategies and engagement models • Monitor external environment changes and integrate learnings into strategy updates Support Cross ‑ Functional Collaboration and coordination • Collaborate closely with cross‑functional teams including Medical Affairs, Commercial TAs, and Finance, Strategic Account teams and Customer Experience roles • Influence without formal authority to align stakeholders on V&A priorities • Foster effective ways of working within matrix and portfolio environments External Stakeholder Engagement and Negotiation • Build and maintain strong relationships with external decision makers • Represent the organization in access‑related discussions and forums • Integrate external stakeholder feedback into strategy refinement • Adjust negotiation approaches based on market and policy context Portfolio Maintenance & Lifecycle Management • Support maintenance and evolution of the value proposition for in‑market brands • Oversee and support lifecycle access activities (submission renewals, HTA updates, line extensions) • Support contract renewals, pricing reviews, and access renegotiations Business Insight and Performance Management • Provide V&A input into business cases and portfolio decisions • Monitor access performance using defined Key Performance Indicators (KPIs) • Track reimbursement, pricing, and listing milestones • Share best practices and lessons learned across brands and teams • Support continuous performance review and optimization Ideal Background Education: • University degree in life sciences, economics, or related field • Advanced degree is an advantage but not mandatory Languages: • English & French • Arabic is required Experience/Professional Requirement: • 5–8 years in market access, pricing, or reimbursement roles • Experience within pharmaceutical or healthcare environment • Proven exposure to national access or payer negotiations • Experience across product launch and lifecycle phases Functional capabilities • Strong understanding of pricing and reimbursement sy